What is the current stock price of Carl Zeiss Meditec AG?

As of the latest data, the stock is priced at €42.84, reflecting a 1.79% decline from the previous session's close of €43.62. This positions it near the lower range of its day low at €42.66.

How has Carl Zeiss Meditec AG performed over the past year?

The stock has experienced a significant decline over the past year, with a 12-month performance showing a 29.01% drop. This decline reflects broader market challenges and sector-specific pressures in the healthcare industry.

What technical indicators are influencing Carl Zeiss Meditec AG's stock?

Current technical indicators show a mixed outlook. The RSI at 50 indicates neutrality, while a MACD of -0.12 hints at a bearish momentum. The ADX of 15.08 suggests a weak trend prevailing in recent sessions.

What is the projected earning outlook for Carl Zeiss Meditec AG?

Meyka AI's analyst forecast expects a yearly price target of €35.83, reflecting a cautious outlook amidst current financial and sector challenges. The upcoming earnings announcement will provide further insights.

What are the strategic growth areas for Carl Zeiss Meditec AG?

The company is focusing on innovation in ophthalmic and microsurgery solutions, with potential growth expected through increased R&D investment and expansion in emerging markets, which are seen as pivotal to its recovery strategy.

DE Stocks

Carl Zeiss Meditec AG: Navigating a Year of Challenges on the German Exchange

ByHuzaifa Zahoor December 11, 2025December 11, 2025

Carl Zeiss Meditec AG (AFX.DE), a prominent player in the medical technology industry, has experienced a challenging year on the German exchange. Recently priced at €42.84, the company’s stock has seen a noticeable decline of 1.79% just ahead of their latest earnings announcement. This article delves into the critical financial metrics, market sentiment, and technical indicators shaping the company’s current trajectory.